Submit Deal

Announced

9 Jan 2020

Completed

9 Jan 2020

BIOBank completed the acquisition of Neutromedics.

Synopsis

NewAlpha Asset Management and Capital Croissance-backed BIOBank, a French human origin bone bank, completed the acquisition of Neutromedics, a Swiss distributor of orthobiologics and orthopedic implants. Financial terms were not disclosed.

Principals

target

Neutromedics

bidder

New Alpha Asset Management

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

walter hollenstein

Chairman at NEUTROMEDICS AG

Manager

target

Deal

n/a

Total Value

Bidder Team (9)

daniel hasler

Partner at Homburger

Lawyer

bidder

Deals

£ 28.48 B

Total Value

margrit marti

Associate at Homburger

Lawyer

bidder

Deals

£ 7.33 B

Total Value

franz hoffet

Partner at Homburger

Lawyer

bidder

Deals

£ 12.48 B

Total Value

peter müller

Counsel at Homburger

Lawyer

bidder

Deals

£ 5.81 B

Total Value

gregor schifferle

Junior Associate at Homburger

Lawyer

bidder

Deals

£ 12.41 B

Total Value

andrea ziswiler

Associate at Homburger

Lawyer

bidder

Deals

n/a

Total Value

patrick joucla

Chairman at BIOBANK

Manager

bidder

Deal

n/a

Total Value

alienor de dardel

Associate at Homburger

Lawyer

bidder

Deals

£ 10 M

Total Value

yves bianchi

Associate at Homburger

Lawyer

bidder

Deals

£ 9.69 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy